Target intelligence / Profile preview

Immunoglobulin heavy variable 3-75 (IGHV3-75)

Target
IGHV3-75
Molecular classification
Immunoglobulin variable region gene segment, Germline gene of the immunoglobulin heavy chain, Immunoglobulin superfamily (IgSF)
01

Overview

Immunoglobulin heavy variable 3-75 (IGHV3-75) is a germline gene segment that encodes the variable (V) domain of the heavy chain in immunoglobulins (antibodies)[1][2]. This variable domain, through V(D)J recombination and subsequent somatic hypermutation, contributes to the enormous diversity of antibodies produced by B cells in the adaptive immune system[1][2]. Each antibody’s antigen-binding site is formed by a unique combination of variable domains from both the heavy and light chains, enabling specific recognition of a vast array of antigens[1]. IGHV3-75 is one out of many similar variable genes in the human genome and is not a protein or molecular target for therapy on its own. The designation VH3 refers to its membership in the VH3 subfamily of immunoglobulin heavy variable genes, which all encode slightly different variable region sequences, further increasing antibody repertoire diversity[2]. These gene segments are located in the immunoglobulin heavy chain locus on chromosome 14 in humans. Summary: IGHV3-75 is a genetic segment contributing to antibody diversity, not a standalone therapeutic target, receptor, or biomarker. It is correctly labeled as a germline immunoglobulin gene variable region segment and used in antibody gene recombination, but there is no evidence for a direct therapeutic or biological targeting relevance for this gene itself[1][2].

Other names
3-75PIGHV375VH3-75VH3
02

Biological functions

Antigen recognition and binding (as part of antibody heavy chain variable region)Initiation of B-cell immune response (after antigen binding and clonal selection)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-75 (IGHV3-75).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-75 (IGHV3-75).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call